New creatinine- and cystatin C-based equations designed to estimate glomerular filtration rate (GFR) without incorporating race were published in the New England Journal of Medicine on 2021-01-01. This pivotal publication introduces a revised method for assessing kidney function, which has broad implications for clinical practice and research, particularly in the context of managing chronic kidney disease with drugs like dapagliflozin.
Background
Dapagliflozin is a medication that belongs to the class of sodium-glucose cotransporter 2 (SGLT2) inhibitors. These inhibitors have demonstrated significant effects on kidney function, particularly in patients with advanced chronic kidney disease. The development and adoption of new, race-free equations for estimating glomerular filtration rate (GFR) are crucial for accurately monitoring and evaluating kidney health in these patient populations, providing a more precise basis for assessing the impact of therapies like SGLT2 inhibitors.
What this means
The publication of new creatinine- and cystatin C-based equations to estimate GFR without race represents a significant advancement in clinical nephrology. These equations aim to provide a more standardized and equitable assessment of kidney function, addressing historical concerns about racial bias in GFR calculations. For clinicians, this means a revised approach to diagnosing and staging chronic kidney disease, which can influence treatment pathways and medication management. For patients, particularly those with advanced chronic kidney disease who may be treated with medications such as dapagliflozin, these new equations offer the potential for more accurate monitoring of their kidney health and a more personalized approach to care. This change is expected to impact how the effects of sodium-glucose cotransporter 2 inhibitors on kidney function are evaluated in clinical practice and research.
Source
The information regarding the publication of these new GFR equations was obtained from PubMed, a comprehensive database of biomedical literature. The article, titled 'New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race', was published on 2021-01-01 and is accessible via the pubmed.ncbi.nlm.nih.gov domain.